“Many cases have a fairly lengthy ascending aorta,” said Dr. Montero-Baker during the transmission. “This case is a little more complicated because of stenosis. It is a great case to try a multilayer graft.”
The patient had already had a triple heart bypass, which made him a good candidate for an endovascular procedure as opposed to having another open procedure. “He was turned down by cardiothoracic surgeons,” said Dr. Montero-Baker “He was out of open options but in desperate need of a solution.”
Dr. Montero-Baker explained that the major advantage of the device is that it will change the flow dynamics, which lessens the tension on the aneurysm wall. “It is fairly different from other classical aorta devices,” he said.
The device is currently not approved for use in the United States, but an application is in to the FDA for approval. The unique opportunity to show this first-ever broadcast, one of 32 live case transmissions from eight sites during the three-day conference, supports NCVH’s goal of introducing attendees to new technologies.
“This allows attendees to get real-world experience on state-of-the-
About CARDIATIS MULTILAYER TECHNOLOGY
The current endovascular approach to treating aortic aneurysm relies on the use of covered stents that mechanically blocks the aneurysm in an effort to eliminate it from circulation. By creating an active barrier based on the laws of fluid dynamics Cardiatis Multilayer technology platform challenges the covered stent mechanical barrier concept and introduces a new paradigm for treating aortic aneurysms. The space-age 3D geometrical design of a Cardiatis stent modifies flow within the aorta in a way that reduces pressure within the aneurysm thus collapsing the aneurismal sac while preserving any vital collateral circulation. Cardiatis uncovered multilayer braided stent is low profile, easy to deploy and its hemodynamic modulating effects have been proven in-silico, in-vitro as well as clinically. Visit www.cardiatis.com for additional information.
New Cardiovascular Horizons (NCVH) is a peripheral intervention conference focusing on peripheral artery disease (PAD) with a special emphasis on critical limb ischemia (CLI). The goal of NCVH is to bring together key disciplines to focus on the team approach to total cardiovascular care in patients with PAD and CLI. This approach creates an environment for clinical collaboration to address the continuum of care for the patient. NCVH is hosted annually in New Orleans and is well known for hospitality and a family friendly environment. NCVH 2014 is scheduled for May 28-30, 2014. Visit www.ncvh.org to learn more.